Filling the need for trusted information on national health issues…

Cipla Could Provide Open Access To Patent For First-Line ARV

LiveMint: Cipla may put patent for new HIV drug in open access pool
“Cipla Ltd, which competed with multinational drug firms by cutting HIV treatment cost to a fraction of the prevailing rate, is hoping to make a similar impact with a new four-drug combination to treat HIV/AIDS in infants and children. The drug is in the advanced stage of development. The Indian firm led by Y.K. Hamied, which will own the intellectual property rights of the first-line antiretroviral (ARV) combination therapy, plans to put the technology in a free access patent pool, two company executives said, requesting anonymity…” (Unnirkishnan, 3/10).

The Henry J. Kaiser Family Foundation Headquarters: 2400 Sand Hill Road, Menlo Park, CA 94025 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/KaiserFamFound

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in Menlo Park, California.